BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4613462)

  • 1. Hemodynamic drug interactions.
    Nies AS; Shand DG; Branch RA
    Cardiovasc Clin; 1974; 6(2):43-53. PubMed ID: 4613462
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reduction of lidocaine clearance by dl-propranolol: an example of hemodynamic drug interaction.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Pharmacol Exp Ther; 1973 Feb; 184(2):515-9. PubMed ID: 4688187
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic drug interactions: the reduction of oxyphenbutazone clearance by dl-propranol in the dog.
    Branch RA; Shand DG; Nies AS
    J Pharmacol Exp Ther; 1973 Oct; 187(1):133-7. PubMed ID: 4746322
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of propranolol and glucagon on the pharmacokinetics of antipyrine and sodium salicylate.
    Orszulak-Michalak D; Kaszubski P
    Pharmazie; 1987 Jun; 42(6):394-6. PubMed ID: 3671460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme induction in sheep: effects of phenobarbital on in vivo and in vitro drug metabolism.
    Shetty SN; Himes JA; Edds GT
    Am J Vet Res; 1972 May; 33(5):935-42. PubMed ID: 4112405
    [No Abstract]   [Full Text] [Related]  

  • 7. Increase in hepatic blood flow and d-propranolol clearance by glucagon in the monkey.
    Branch RA; Shand DG; Nies AS
    J Pharmacol Exp Ther; 1973 Dec; 187(3):581-7. PubMed ID: 4203721
    [No Abstract]   [Full Text] [Related]  

  • 8. [Kidney and drugs - urinary lithiasis. Pharmacokinetic glossary].
    Balant L
    Rev Med Suisse Romande; 1980 Nov; 100(11):949-56. PubMed ID: 7466067
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic and environmental factors affecting drug response in man.
    Vesell ES
    Fed Proc; 1972; 31(4):1253-69. PubMed ID: 4114107
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacologic antagonism of propranolol in dogs. III. Effects of dopamine-isoproterenol and glucagon on hemodynamics and myocardial oxygen consumption in ischemic hearts during chronic propranolol administration.
    Wei J; Spotnitz HM; Spotnitz WD; Benvenisty AI; Haasler GB; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1984 May; 87(5):732-42. PubMed ID: 6717051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic profile of antipyrine in young rhesus monkeys (Macaca mulatta) with protein energy malnutrition.
    Sharma B; Mehta S; Nain CK; Mathur VS
    Drug Nutr Interact; 1985; 3(2):93-8. PubMed ID: 3921335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vasoactive action of glucagon on the portal system: II. Study of the hepatic vascular bed in dogs].
    de Miguel E; Ginestal JM; Salgado G; Veiga JL
    Rev Esp Enferm Apar Dig; 1981 Oct; 60(4):357-66. PubMed ID: 7330405
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in the effect of drugs due to reciprocal interference with their protein binding and catabolism].
    Remmer H
    Dtsch Med Wochenschr; 1974 Mar; 99(9):413-9. PubMed ID: 4857236
    [No Abstract]   [Full Text] [Related]  

  • 14. Clearance and biologic half-life as indices of intrinsic hepatic metabolism.
    Perrier D; Gibaldi M
    J Pharmacol Exp Ther; 1974 Oct; 191(1):17-24. PubMed ID: 4423599
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: The influence of glucagon on regional blood flow in the rhesus monkey.
    Branch RA; Nies AS; Shand DG
    Br J Pharmacol; 1973 Sep; 49(1):149P. PubMed ID: 4207042
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of haemodynamic alterations on drug disposition. Haemodynamic drug interactions.
    Nies AS
    Neth J Med; 1977; 20(2):46-58. PubMed ID: 325425
    [No Abstract]   [Full Text] [Related]  

  • 17. Altered hepatic blood flow and drug disposition.
    Nies AS; Shand DG; Wilkinson GR
    Clin Pharmacokinet; 1976; 1(2):135-55. PubMed ID: 13954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of phenobarbital on the pharmacokinetics of propranolol in pregnancy.
    Hoffmann-Traeger A; Peiker G; Glöckner R; Wittmann I; Balogh A; Henschel L
    Biol Res Pregnancy Perinatol; 1987; 8(2 2D Half):57-9. PubMed ID: 3427136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
    Vu VT; Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between propranolol plasma protein binding, glycoprotein concentration, and enzyme induction following phenobarbital administration in the dog.
    Abramson FP; Robinson D; Bai SA
    Biochem Pharmacol; 1983 Sep; 32(17):2618-20. PubMed ID: 6615557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.